Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-051675

Chief Executive Officer sold 25,000 shares at an average $64.61 ($1,615,160)

  • Chief Executive Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2022-09-28 Option exercise +25,000 $16.21 $405,250 315,279 D
Kulkarni Samarth Chief Executive Officer 2022-09-28 Sale −23,200 $64.58 $1,498,214 292,079 D
Kulkarni Samarth Chief Executive Officer 2022-09-28 Sale −1,800 $64.97 $116,946 290,279 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2022-09-28 Option exercise · Stock Option (Right to Buy) −25,000 33,333 D
Open-market sales · 25,000 sh · avg $64.61 · $1,615,160
Loading xslF345X03/doc4.xml…